Search - tctmd.com

Displaying 841 - 860 of 871

Sort: Relevancy | Date

News Daily News

Iodinated Contrast Agents Tied to Potential Thyroid Dysfunction

Yael L. Maxwell

January 30, 2012

News Daily News

Women Benefit From TAVR as Much as Men, Maybe More

Jason Kahn

January 29, 2012

News Daily News

Induced Diuresis with Matched Hydration Reduces Contrast Nephropathy

January 17, 2012

News Conference News

Compelling Unmet Needs in Treatment of CVD

November 07, 2011

News Industry News

Medtronic Starts Landmark Study of Hypertension Treatment

October 26, 2011

News Daily News

DES Shows Slight Edge Over BMS in Patients with Kidney Disease

L.A. McKeown

October 21, 2011

News Daily News

HORIZONS-AMI: CKD Patients Fare Poorly Regardless of Stent Type, Antithrombotic Regimen

Leah Lawrence

September 29, 2011

News Daily News

Frailty Status Improves Prediction of Long-term Outcomes in PCI Patients

Caitlin E. Cox

September 09, 2011

News Conference News

Japanese ACS Patients Fare Better with High Rates of Intensive Treatment

September 01, 2011

News Conference News

Novel Anticoagulants Showing Benefits in A-fib Subgroups

August 29, 2011

News Daily News

REMEDIAL II Published: New Therapy Prevents Contrast-Induced Kidney Damage

Caitlin E. Cox

August 19, 2011

News Industry News

REMEDIAL II Trial of PLC's RenalGuard® Article Published in Circulation

August 18, 2011

News Daily News

Carbon Dioxide Angiography May Be Alternative to Iodinated Contrast in High-Risk Patients

L.A. McKeown

August 16, 2011

News Daily News

Natriuretic Peptide Protects Kidney Function in CABG Patients with CKD

August 15, 2011

News Industry News

Abbott Receives U.S. FDA Approval for RX Herculink Elite® Renal Stent System for Treatment of Renal Artery Disease

August 10, 2011

News Daily News

High Homocysteine Levels Linked with Contrast Nephropathy

Jason Kahn

July 28, 2011

News Daily News

Smaller Delivery System Means Fewer Complications with Aortic Valve Implantation

L.A. McKeown

July 19, 2011

News Industry News

Medtronic Gets Go-Ahead from FDA for Study of Novel Treatment for High Blood Pressure

July 11, 2011

News Daily News

Renal Dysfunction Takes Toll on Carotid Revascularization Outcomes

June 22, 2011

News Industry News

Study Shows Improved Patient Management and Outcome using Abbott’s Sensitive Troponin Assay

May 18, 2011

Advertisement

Iodinated Contrast Agents Tied to Potential Thyroid Dysfunction

Women Benefit From TAVR as Much as Men, Maybe More

Induced Diuresis with Matched Hydration Reduces Contrast Nephropathy

Compelling Unmet Needs in Treatment of CVD

Medtronic Starts Landmark Study of Hypertension Treatment

DES Shows Slight Edge Over BMS in Patients with Kidney Disease

HORIZONS-AMI: CKD Patients Fare Poorly Regardless of Stent Type, Antithrombotic Regimen

Frailty Status Improves Prediction of Long-term Outcomes in PCI Patients

Japanese ACS Patients Fare Better with High Rates of Intensive Treatment

Novel Anticoagulants Showing Benefits in A-fib Subgroups

REMEDIAL II Published: New Therapy Prevents Contrast-Induced Kidney Damage

REMEDIAL II Trial of PLC's RenalGuard® Article Published in Circulation

Carbon Dioxide Angiography May Be Alternative to Iodinated Contrast in High-Risk Patients

Natriuretic Peptide Protects Kidney Function in CABG Patients with CKD

Abbott Receives U.S. FDA Approval for RX Herculink Elite® Renal Stent System for Treatment of Renal Artery Disease

High Homocysteine Levels Linked with Contrast Nephropathy

Smaller Delivery System Means Fewer Complications with Aortic Valve Implantation

Medtronic Gets Go-Ahead from FDA for Study of Novel Treatment for High Blood Pressure

Renal Dysfunction Takes Toll on Carotid Revascularization Outcomes

Study Shows Improved Patient Management and Outcome using Abbott’s Sensitive Troponin Assay

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content